TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs9276916
log Bayes Factor = 137.921
Chromosome 6   position 32,866,095  (GRCh37) Explore rs9276916 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E03.9 Hypothyroidism, unspecified
0.000 0.000 1.000
E10.9 Without complications
0.000 0.000 1.000
E10.3 With ophthalmic complications
0.000 0.000 1.000
E10.1 With ketoacidosis
0.000 0.000 1.000
J45.9 Asthma, unspecified
0.000 0.000 1.000
K90.0 Coeliac disease
0.000 0.000 1.000
E10 Insulin-dependent diabetes mellitus
0.000 0.000 1.000
E10-E14 Diabetes mellitus
0.000 0.000 1.000
E00-E07 Disorders of thyroid gland
0.000 0.000 1.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.000 1.000
E03 Other hypothyroidism
0.000 0.000 1.000
E16.2 Hypoglycaemia, unspecified
0.000 0.000 1.000
E16 Other disorders of pancreatic internal secretion
0.000 0.000 1.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.000 1.000
E10.4 With neurological complications
0.000 0.000 1.000
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.001 0.999
L40.9 Psoriasis, unspecified
0.999 0.001 0.000
L40 Psoriasis
0.995 0.005 0.000
L40.5 Arthropathic psoriasis
0.995 0.005 0.000
E14 Unspecified diabetes mellitus
0.000 0.008 0.992
G35 Multiple sclerosis
0.992 0.008 0.000
E05.9 Thyrotoxicosis, unspecified
0.000 0.009 0.991
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.011 0.989
E14.3 With ophthalmic complications
0.000 0.014 0.986
E10.2 With renal complications
0.000 0.022 0.978
E10.8 With unspecified complications
0.000 0.022 0.978
E10.0 With coma
0.000 0.043 0.957
E10.5 With peripheral circulatory complications
0.000 0.071 0.929
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.111 0.889
E10.6 With other specified complications
0.000 0.159 0.841
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.162 0.838
E03.8 Other specified hypothyroidism
0.000 0.168 0.832
E40-E46 Malnutrition
0.000 0.182 0.818
E14.8 With unspecified complications
0.000 0.188 0.812
L40.1 Generalised pustular psoriasis
0.811 0.189 0.000
E06 Thyroiditis
0.000 0.215 0.785
L40.4 Guttate psoriasis
0.764 0.236 0.000
E14.5 With peripheral circulatory complications
0.000 0.239 0.761
E13 Other specified diabetes mellitus
0.000 0.239 0.761
E14.6 With other specified complications
0.000 0.245 0.755
L40.8 Other psoriasis
0.730 0.270 0.000
E14.2 Withrenal complications
0.000 0.274 0.726
E10.7 With multiple complications
0.000 0.283 0.717
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.283 0.717
E00 Congenital iodine-deficiency syndrome
0.000 0.283 0.717
E12 Malnutrition-related diabetes mellitus
0.000 0.283 0.717
E03.5 Myxoedema coma
0.000 0.283 0.717
E03.4 Atrophy of thyroid (acquired)
0.000 0.283 0.717
E03.3 Postinfectious hypothyroidism
0.000 0.283 0.717
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.283 0.717
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.283 0.717
E16.4 Abnormal secretion of gastrin
0.000 0.283 0.717
E16.3 Increased secretion of glucagon
0.000 0.283 0.717
E15 Nondiabetic hypoglycaemic coma
0.000 0.283 0.717
E05.5 Thyroid crisis or storm
0.000 0.284 0.716
E05.4 Thyrotoxicosis factitia
0.000 0.284 0.716
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.284 0.716
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.284 0.716
E14.1 With ketoacidosis
0.000 0.285 0.714
L40.2 Acrodermatitis continua
0.714 0.286 0.000
E14.7 With multiple complications
0.000 0.288 0.711
E14.0 With coma
0.000 0.288 0.711
K90 Intestinal malabsorption
0.000 0.291 0.709
E16.1 Other hypoglycaemia
0.000 0.310 0.690
E03.1 Congenital hypothyroidism without goitre
0.000 0.312 0.688
E46 Unspecified protein-energy malnutrition
0.000 0.312 0.688
E14.4 With neurological complications
0.000 0.324 0.676
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.330 0.670
L40.3 Pustulosis palmaris et plantaris
0.630 0.370 0.000
E06.3 Autoimmune thyroiditis
0.000 0.371 0.629
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.385 0.615
E05.8 Other thyrotoxicosis
0.000 0.396 0.604
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.413 0.586
E45 Retarded development following protein-energy malnutrition
0.000 0.413 0.586
E43 Unspecified severe protein-energy malnutrition
0.000 0.413 0.586
E42 Marasmic kwashiorkor
0.000 0.413 0.586
E41 Nutritional marasmus
0.000 0.413 0.586
E40 Kwashiorkor
0.000 0.413 0.586
E13.9 Without complications
0.000 0.414 0.586
E06.9 Thyroiditis, unspecified
0.000 0.425 0.575
K90.9 Intestinal malabsorption, unspecified
0.000 0.431 0.569
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.431 0.568
E06.4 Drug-induced thyroiditis
0.000 0.437 0.563
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.437 0.563
E06.0 Acute thyroiditis
0.000 0.437 0.563
E20-E35 Disorders of other endocrine glands
0.000 0.437 0.563
E06.5 Other chronic thyroiditis
0.000 0.438 0.562
E06.1 Subacute thyroiditis
0.000 0.445 0.555
E13.3 With ophthalmic complications
0.000 0.449 0.551
E13.8 With unspecified complications
0.000 0.454 0.546
E13.7 With multiple complications
0.000 0.454 0.546
E13.6 With other specified complications
0.000 0.454 0.546
E13.5 With peripheral circulatory complications
0.000 0.454 0.546
E13.4 With neurological complications
0.000 0.454 0.546
E13.2 With renal complications
0.000 0.454 0.546
E13.1 With ketoacidosis
0.000 0.454 0.546
E13.0 With coma
0.000 0.454 0.546
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.486 0.514
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.486 0.514
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.486 0.514
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.486 0.514
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.486 0.514
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.486 0.514
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.486 0.514
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.486 0.514
E12.9 Without complications
0.000 0.486 0.514
E12.8 With unspecified complications
0.000 0.486 0.514
E12.7 With multiple complications
0.000 0.486 0.514
E12.6 With other specified complications
0.000 0.486 0.514
E12.5 With peripheral circulatory complications
0.000 0.486 0.514
E12.4 With neurological complications
0.000 0.486 0.514
E12.3 With ophthalmic complications
0.000 0.486 0.514
E12.2 With renal complications
0.000 0.486 0.514
E12.1 With ketoacidosis
0.000 0.486 0.514
E12.0 With coma
0.000 0.486 0.514
K90.3 Pancreatic steatorrhoea
0.000 0.491 0.508
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.491 0.508
K90.1 Tropical sprue
0.000 0.491 0.508
K90.8 Other intestinal malabsorption
0.000 0.498 0.501
E24 Cushing's syndrome
0.000 0.508 0.492
E11 Non-insulin-dependent diabetes mellitus
0.000 0.510 0.490
E14.9 Without complications
0.000 0.514 0.486
E07 Other disorders of thyroid
0.000 0.527 0.473
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.531 0.469
E11.2 With renal complications
0.000 0.544 0.456
E22 Hyperfunction of pituitary gland
0.000 0.560 0.440
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.567 0.433
E44.1 Mild protein-energy malnutrition
0.000 0.579 0.420
E44.0 Moderate protein-energy malnutrition
0.000 0.579 0.420
E29 Testicular dysfunction
0.000 0.595 0.405
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.596 0.404
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.596 0.404
E32 Diseases of thymus
0.000 0.596 0.404
E30 Disorders of puberty, not elsewhere classified
0.000 0.596 0.404
E50-E64 Other nutritional deficiencies
0.003 0.598 0.399
E24.2 Drug-induced Cushing's syndrome
0.000 0.600 0.400
E11.5 With peripheral circulatory complications
0.000 0.605 0.395
E24.0 Pituitary-dependent Cushing's disease
0.000 0.607 0.393
E23 Hypofunction and other disorders of pituitary gland
0.000 0.611 0.389
E28 Ovarian dysfunction
0.000 0.612 0.388
E11.1 With ketoacidosis
0.000 0.613 0.387
E25 Adrenogenital disorders
0.000 0.614 0.386
E24.9 Cushing's syndrome, unspecified
0.000 0.617 0.383
E26 Hyperaldosteronism
0.000 0.621 0.379
E22.1 Hyperprolactinaemia
0.000 0.624 0.376
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.628 0.372
E11.6 With other specified complications
0.000 0.634 0.366
E20 Hypoparathyroidism
0.000 0.635 0.365
J45 Asthma
0.000 0.641 0.359
E31 Polyglandular dysfunction
0.000 0.642 0.357
E24.8 Other Cushing's syndrome
0.000 0.647 0.353
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.647 0.353
E24.3 Ectopic ACTH syndrome
0.000 0.647 0.353
E24.1 Nelson's syndrome
0.000 0.647 0.353
E21.2 Other hyperparathyroidism
0.000 0.648 0.352
E11.7 With multiple complications
0.000 0.648 0.351
E21.3 Hyperparathyroidism, unspecified
0.000 0.650 0.350
E61 Deficiency of other nutrient elements
0.001 0.651 0.347
L40.0 Psoriasis vulgaris
0.348 0.652 0.001
E34 Other endocrine disorders
0.000 0.655 0.345
E23.2 Diabetes insipidus
0.000 0.658 0.342
E07.1 Dyshormogenetic goitre
0.000 0.661 0.339
E07.0 Hypersecretion of calcitonin
0.000 0.661 0.339
E21.4 Other specified disorders of parathyroid gland
0.000 0.664 0.336
E28.3 Primary ovarian failure
0.000 0.677 0.323
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.680 0.320
E61.1 Iron deficiency
0.000 0.682 0.318
E22.8 Other hyperfunction of pituitary gland
0.000 0.684 0.316
E07.8 Other specified disorders of thyroid
0.000 0.696 0.304
G35-G37 Demyelinating diseases of the central nervous system
0.300 0.700 0.000
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.706 0.294
E11.8 With unspecified complications
0.000 0.707 0.293
E29.1 Testicular hypofunction
0.000 0.709 0.291
E22.0 Acromegaly and pituitary gigantism
0.000 0.709 0.290
E29.9 Testicular dysfunction, unspecified
0.000 0.710 0.290
E29.8 Other testicular dysfunction
0.000 0.710 0.290
E29.0 Testicular hyperfunction
0.000 0.710 0.290
E30.9 Disorder of puberty, unspecified
0.000 0.710 0.289
E30.8 Other disorders of puberty
0.000 0.710 0.289
E30.1 Precocious puberty
0.000 0.710 0.289
E30.0 Delayed puberty
0.000 0.710 0.289
E32.9 Disease of thymus, unspecified
0.000 0.710 0.289
E32.8 Other diseases of thymus
0.000 0.710 0.289
E32.1 Abscess of thymus
0.000 0.710 0.289
E32.0 Persistent hyperplasia of thymus
0.000 0.710 0.289
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.710 0.289
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.710 0.289
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.710 0.289
E64 Sequelae of malnutrition and other nutritional deficiencies
0.002 0.712 0.286
E50 Vitamin A deficiency
0.002 0.712 0.286
E60 Dietary zinc deficiency
0.002 0.712 0.286
E59 Dietary selenium deficiency
0.002 0.712 0.286
E54 Ascorbic acid deficiency
0.002 0.712 0.286
E52 Niacin deficiency [pellagra]
0.002 0.712 0.286
E23.7 Disorder of pituitary gland, unspecified
0.000 0.712 0.288
E51 Thiamine deficiency
0.002 0.718 0.280
L40-L45 Papulosquamous disorders
0.280 0.720 0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.721 0.279
E23.1 Drug-induced hypopituitarism
0.000 0.721 0.279
N08.3 Glomerular disorders in diabetes mellitus
0.000 0.721 0.279
E28.9 Ovarian dysfunction, unspecified
0.000 0.722 0.278
E28.8 Other ovarian dysfunction
0.000 0.722 0.278
E28.1 Androgen excess
0.000 0.722 0.278
E28.0 Oestrogen excess
0.000 0.722 0.278
E25.9 Adrenogenital disorder, unspecified
0.000 0.723 0.277
E25.8 Other adrenogenital disorders
0.000 0.723 0.277
E63 Other nutritional deficiencies
0.002 0.725 0.273
E26.8 Other hyperaldosteronism
0.000 0.728 0.271
E26.1 Secondary hyperaldosteronism
0.000 0.728 0.271
N08 Glomerular disorders in diseases classified elsewhere
0.000 0.730 0.270
N00-N08 Glomerular diseases
0.000 0.734 0.266
N04 Nephrotic syndrome
0.000 0.735 0.265
E23.6 Other disorders of pituitary gland
0.000 0.737 0.263
N05 Unspecified nephritic syndrome
0.000 0.737 0.263
E26.9 Hyperaldosteronism, unspecified
0.000 0.737 0.263
J45.0 Predominantly allergic asthma
0.000 0.738 0.262
E20.8 Other hypoparathyroidism
0.000 0.738 0.262
E20.1 Pseudohypoparathyroidism
0.000 0.738 0.262
E20.0 Idiopathic hypoparathyroidism
0.000 0.738 0.262
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.740 0.260
N04.9 Unspecified
0.000 0.741 0.259
E65-E68 Obesity and other hyperalimentation
0.000 0.741 0.258
E56 Other vitamin deficiencies
0.002 0.743 0.255
E26.0 Primary hyperaldosteronism
0.000 0.743 0.257
E34.3 Short stature, not elsewhere classified
0.000 0.743 0.256
E31.9 Polyglandular dysfunction, unspecified
0.000 0.743 0.256
E31.8 Other polyglandular dysfunction
0.000 0.743 0.256
E31.1 Polyglandular hyperfunction
0.000 0.743 0.256
E11.0 With coma
0.000 0.744 0.256
N05.9 Unspecified
0.000 0.748 0.252
E61.9 Deficiency of nutrient element, unspecified
0.001 0.750 0.249
E61.8 Deficiency of other specified nutrient elements
0.001 0.750 0.249
E61.7 Deficiency of multiple nutrient elements
0.001 0.750 0.249
E61.6 Vanadium deficiency
0.001 0.750 0.249
E61.5 Molybdenum deficiency
0.001 0.750 0.249
E61.4 Chromium deficiency
0.001 0.750 0.249
E61.3 Manganese deficiency
0.001 0.750 0.249
E61.0 Copper deficiency
0.001 0.750 0.249
E34.8 Other specified endocrine disorders
0.000 0.752 0.248
E34.5 Androgen resistance syndrome
0.000 0.752 0.248
E34.4 Constitutional tall stature
0.000 0.752 0.248
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.752 0.248
E34.1 Other hypersecretion of intestinal hormones
0.000 0.752 0.248
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.247 0.753 0.000
J45.1 Nonallergic asthma
0.000 0.758 0.242
E34.0 Carcinoid syndrome
0.000 0.761 0.239
E58 Dietary calcium deficiency
0.002 0.766 0.232
E21.0 Primary hyperparathyroidism
0.000 0.766 0.234
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.230 0.770 0.000
J45.8 Mixed asthma
0.000 0.775 0.224
E61.2 Magnesium deficiency
0.001 0.777 0.222
E20.9 Hypoparathyroidism, unspecified
0.000 0.777 0.223
E11.9 Without complications
0.000 0.779 0.221
N04.1 Focal and segmental glomerular lesions
0.000 0.779 0.221
N04.2 Diffuse membranous glomerulonephritis
0.000 0.779 0.220
N05.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.780 0.220
N05.1 Focal and segmental glomerular lesions
0.000 0.781 0.219
E31.0 Autoimmune polyglandular failure
0.000 0.790 0.210
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases
0.000 0.790 0.210
E50.9 Vitamin A deficiency, unspecified
0.002 0.793 0.205
E50.8 Other manifestations of vitamin A deficiency
0.002 0.793 0.205
E50.7 Other ocular manifestations of vitamin A deficiency
0.002 0.793 0.205
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.002 0.793 0.205
E50.5 Vitamin A deficiency with night blindness
0.002 0.793 0.205
E50.4 Vitamin A deficiency with keratomalacia
0.002 0.793 0.205
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.002 0.793 0.205
E50.2 Vitamin A deficiency with corneal xerosis
0.002 0.793 0.205
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.002 0.793 0.205
E50.0 Vitamin A deficiency with conjunctival xerosis
0.002 0.793 0.205
E64.9 Sequelae of unspecified nutritional deficiency
0.002 0.793 0.205
E64.8 Sequelae of other nutritional deficiencies
0.002 0.793 0.205
E64.3 Sequelae of rickets
0.002 0.793 0.205
E64.2 Sequelae of vitamin C deficiency
0.002 0.793 0.205
E64.1 Sequelae of vitamin A deficiency
0.002 0.793 0.205
E64.0 Sequelae of protein-energy malnutrition
0.002 0.793 0.205
L42 Pityriasis rosea
0.206 0.794 0.000
N05.2 Diffuse membranous glomerulonephritis
0.000 0.796 0.204
E51.9 Thiamine deficiency, unspecified
0.002 0.798 0.201
E51.8 Other manifestations of thiamine deficiency
0.002 0.798 0.201
E51.1 Beriberi
0.002 0.798 0.201
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.202 0.798 0.000
L44 Other papulosquamous disorders
0.201 0.799 0.000
L41 Parapsoriasis
0.201 0.799 0.000
L45 Papulosquamous disorders in diseases classified elsewhere
0.201 0.799 0.000
G36 Other acute disseminated demyelination
0.198 0.802 0.000
E63.8 Other specified nutritional deficiencies
0.002 0.802 0.196
E63.1 Imbalance of constituents of food intake
0.002 0.802 0.196
E63.0 Essential fatty acid [EFA] deficiency
0.002 0.802 0.196
E51.2 Wernicke's encephalopathy
0.002 0.804 0.195
N05.7 Diffuse crescentic glomerulonephritis
0.000 0.806 0.194
N08.8 Glomerular disorders in other diseases classified elsewhere
0.000 0.806 0.193
N08.1 Glomerular disorders in neoplastic diseases
0.000 0.806 0.193
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere
0.000 0.806 0.193
E53 Deficiency of other B group vitamins
0.001 0.807 0.192
N07 Hereditary nephropathy, not elsewhere classified
0.000 0.809 0.191
N06 Isolated proteinuria with specified morphological lesion
0.000 0.809 0.191
N01 Rapidly progressive nephritic syndrome
0.000 0.809 0.191
N00 Acute nephritic syndrome
0.000 0.809 0.191
N04.8 Other
0.000 0.810 0.190
N04.7 Diffuse crescentic glomerulonephritis
0.000 0.810 0.190
N04.6 Dense deposit disease
0.000 0.810 0.190
N04.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.810 0.190
N04.4 Diffuse endocapillary proliferative glomerulonephritis
0.000 0.810 0.190
N04.3 Diffuse mesangial proliferative glomerulonephritis
0.000 0.810 0.190
N05.6 Dense deposit disease
0.000 0.811 0.189
N05.4 Diffuse endocapillary proliferative glomerulonephritis
0.000 0.811 0.189
N05.0 Minor glomerular abnormality
0.000 0.811 0.189
E11.3 With ophthalmic complications
0.000 0.813 0.187
N05.3 Diffuse mesangial proliferative glomerulonephritis
0.000 0.813 0.186
E34.9 Endocrine disorder, unspecified
0.000 0.814 0.186
E67 Other hyperalimentation
0.000 0.814 0.185
E68 Sequelae of hyperalimentation
0.000 0.814 0.185
E56.9 Vitamin deficiency, unspecified
0.002 0.815 0.183
E56.8 Deficiency of other vitamins
0.002 0.815 0.183
E56.0 Deficiency of vitamin E
0.002 0.815 0.183
E63.9 Nutritional deficiency, unspecified
0.002 0.815 0.183
G37 Other demyelinating diseases of central nervous system
0.182 0.818 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.178 0.822 0.000
E55 Vitamin D deficiency
0.007 0.822 0.171
E11.4 With neurological complications
0.000 0.824 0.176
E28.2 Polycystic ovarian syndrome
0.000 0.824 0.176
N04.0 Minor glomerular abnormality
0.000 0.824 0.176
E07.9 Disorder of thyroid, unspecified
0.000 0.826 0.174
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism
0.000 0.828 0.172
C82.0 Small cleaved cell, follicular
0.168 0.832 0.000
H36.0 Diabetic retinopathy
0.000 0.833 0.167
T42.0 Hydantoin derivatives
0.166 0.833 0.000
N05.8 Other
0.000 0.834 0.166
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.164 0.836 0.000
N08.5 Glomerular disorders in systemic connective tissue disorders
0.000 0.836 0.164
T42.4 Benzodiazepines
0.163 0.837 0.000
M07.39 Other psoriatic arthropathies (Site unspecified)
0.161 0.839 0.000
M07.3 Other psoriatic arthropathies
0.160 0.840 0.000
M07.30 Other psoriatic arthropathies (Multiple sites)
0.157 0.843 0.000
G37.8 Other specified demyelinating diseases of central nervous system
0.154 0.846 0.000
E56.1 Deficiency of vitamin K
0.002 0.846 0.152
T42.1 Iminostilbenes
0.150 0.850 0.000
C82.3 Follicular lymphoma grade IIIa
0.147 0.852 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.145 0.855 0.000
T42.3 Barbiturates
0.145 0.855 0.000
T42.2 Succinimides and oxazolidinediones
0.145 0.855 0.000
M07.37 Other psoriatic arthropathies (Ankle and foot)
0.145 0.855 0.000
L41.9 Parapsoriasis, unspecified
0.144 0.856 0.000
L41.8 Other parapsoriasis
0.144 0.856 0.000
L41.5 Retiform parapsoriasis
0.144 0.856 0.000
L41.4 Large plaque parapsoriasis
0.144 0.856 0.000
L41.3 Small plaque parapsoriasis
0.144 0.856 0.000
L41.2 Lymphomatoid papulosis
0.144 0.856 0.000
L41.1 Pityriasis lichenoides chronica
0.144 0.856 0.000
L41.0 Pityriasis lichenoides et varioliformis acuta
0.144 0.856 0.000
L44.9 Papulosquamous disorder, unspecified
0.144 0.856 0.000
L44.8 Other specified papulosquamous disorders
0.144 0.856 0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.144 0.856 0.000
L44.3 Lichen ruber moniliformis
0.144 0.856 0.000
L44.2 Lichen striatus
0.144 0.856 0.000
L44.1 Lichen nitidus
0.144 0.856 0.000
L44.0 Pityriasis rubra pilaris
0.144 0.856 0.000
G36.9 Acute disseminated demyelination, unspecified
0.142 0.858 0.000
G36.8 Other specified acute disseminated demyelination
0.142 0.858 0.000
G36.1 Acute and subacute haemorrhagic leukoencephalitis [Hurst]
0.142 0.858 0.000
E53.1 Pyridoxine deficiency
0.001 0.862 0.137
E53.0 Riboflavin deficiency
0.001 0.862 0.137
N00.9 Unspecified
0.000 0.863 0.137
N00.8 Other
0.000 0.863 0.137
N00.7 Diffuse crescentic glomerulonephritis
0.000 0.863 0.137
N00.6 Dense deposit disease
0.000 0.863 0.137
N00.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.863 0.137
N00.4 Diffuse endocapillary proliferative glomerulonephritis
0.000 0.863 0.137
N00.3 Diffuse mesangial proliferative glomerulonephritis
0.000 0.863 0.137
N00.2 Diffuse membranous glomerulonephritis
0.000 0.863 0.137
N00.1 Focal and segmental glomerular lesions
0.000 0.863 0.137
N00.0 Minor glomerular abnormality
0.000 0.863 0.137
N01.9 Unspecified
0.000 0.863 0.137
N01.8 Other
0.000 0.863 0.137
N01.7 Diffuse crescentic glomerulonephritis
0.000 0.863 0.137
N01.6 Dense deposit disease
0.000 0.863 0.137
N01.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.863 0.137
N01.4 Diffuse endocapillary proliferative glomerulonephritis
0.000 0.863 0.137
N01.3 Diffuse mesangial proliferative glomerulonephritis
0.000 0.863 0.137
N01.2 Diffuse membranous glomerulonephritis
0.000 0.863 0.137
N01.1 Focal and segmental glomerular lesions
0.000 0.863 0.137
N01.0 Minor glomerular abnormality
0.000 0.863 0.137
N06.9 Unspecified
0.000 0.863 0.137
N06.8 Other
0.000 0.863 0.137
N06.7 Diffuse crescentic glomerulonephritis
0.000 0.863 0.137
N06.6 Dense deposit disease
0.000 0.863 0.137
N06.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.863 0.137
N06.4 Diffuse endocapillary proliferative glomerulonephritis
0.000 0.863 0.137
N06.3 Diffuse mesangial proliferative glomerulonephritis
0.000 0.863 0.137
N06.2 Diffuse membranous glomerulonephritis
0.000 0.863 0.137
N06.1 Focal and segmental glomerular lesions
0.000 0.863 0.137
N06.0 Minor glomerular abnormality
0.000 0.863 0.137
N07.9 Unspecified
0.000 0.863 0.137
N07.8 Other
0.000 0.863 0.137
N07.7 Diffuse crescentic glomerulonephritis
0.000 0.863 0.137
N07.6 Dense deposit disease
0.000 0.863 0.137
N07.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.863 0.137
N07.4 Diffuse endocapillary proliferative glomerulonephritis
0.000 0.863 0.137
N07.3 Diffuse mesangial proliferative glomerulonephritis
0.000 0.863 0.137
N07.2 Diffuse membranous glomerulonephritis
0.000 0.863 0.137
N07.1 Focal and segmental glomerular lesions
0.000 0.863 0.137
N07.0 Minor glomerular abnormality
0.000 0.863 0.137
M07.34 Other psoriatic arthropathies (Hand)
0.135 0.865 0.000
E67.8 Other specified hyperalimentation
0.000 0.867 0.133
E67.3 Hypervitaminosis D
0.000 0.867 0.133
E67.2 Megavitamin-B6 syndrome
0.000 0.867 0.133
E67.1 Hypercarotenaemia
0.000 0.867 0.133
E67.0 Hypervitaminosis A
0.000 0.867 0.133
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.131 0.868 0.000
E53.9 Vitamin B deficiency, unspecified
0.001 0.869 0.130
G37.5 Concentric sclerosis [Balo]
0.131 0.869 0.000
G37.4 Subacute necrotising myelitis
0.131 0.869 0.000
G37.2 Central pontine myelinolysis
0.131 0.869 0.000
G37.1 Central demyelination of corpus callosum
0.131 0.869 0.000
G37.0 Diffuse sclerosis
0.131 0.869 0.000
C82.2 Large cell, follicular
0.130 0.870 0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.130 0.870 0.000
C82.4 Follicular lymphoma grade IIIb
0.128 0.872 0.000
C82.6 Cutaneous follicle centre lymphoma
0.128 0.872 0.000
C82.5 Diffuse follicle centre lymphoma
0.128 0.872 0.000
E55.0 Rickets, active
0.005 0.872 0.123
N02 Recurrent and persistent haematuria
0.000 0.874 0.126
L43 Lichen planus
0.125 0.875 0.000
G36.0 Neuromyelitis optica [Devic]
0.125 0.875 0.000
M07.38 Other psoriatic arthropathies (Other)
0.125 0.875 0.000
N03 Chronic nephritic syndrome
0.001 0.879 0.120
M07.33 Other psoriatic arthropathies (Forearm)
0.115 0.885 0.000
M07.32 Other psoriatic arthropathies (Upper arm)
0.115 0.885 0.000
M07.36 Other psoriatic arthropathies (Lower leg)
0.112 0.888 0.000
E23.0 Hypopituitarism
0.000 0.890 0.110
G37.9 Demyelinating disease of central nervous system, unspecified
0.108 0.892 0.000
M07.31 Other psoriatic arthropathies (Shoulder region)
0.107 0.893 0.000
E04 Other non-toxic goitre
0.000 0.893 0.106
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)
0.105 0.895 0.000
N02.2 Diffuse membranous glomerulonephritis
0.000 0.895 0.105
E27 Other disorders of adrenal gland
0.001 0.896 0.103
T36-T50 Poisoning by drugs, medicaments and biological substances
0.097 0.903 0.000
N03.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.906 0.093
C82.1 Mixed small cleaved and large cell, follicular
0.093 0.906 0.000
N02.7 Diffuse crescentic glomerulonephritis
0.000 0.909 0.091
N02.6 Dense deposit disease
0.000 0.909 0.091
N02.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.909 0.091
N02.4 Diffuse endocapillary proliferative glomerulonephritis
0.000 0.909 0.091
K90-K93 Other diseases of the digestive system
0.000 0.909 0.091
L43.3 Subacute (active) lichen planus
0.090 0.910 0.000
L43.2 Lichenoid drug reaction
0.090 0.910 0.000
L43.1 Bullous lichen planus
0.090 0.910 0.000
L43.0 Hypertrophic lichen planus
0.090 0.910 0.000
N02.0 Minor glomerular abnormality
0.000 0.911 0.089
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.087 0.913 0.000
N03.7 Diffuse crescentic glomerulonephritis
0.001 0.913 0.086
N03.6 Dense deposit disease
0.001 0.913 0.086
N03.4 Diffuse endocapillary proliferative glomerulonephritis
0.001 0.913 0.086
N03.3 Diffuse mesangial proliferative glomerulonephritis
0.001 0.913 0.086
N03.2 Diffuse membranous glomerulonephritis
0.001 0.913 0.086
N03.0 Minor glomerular abnormality
0.001 0.913 0.086
E65 Localised adiposity
0.001 0.913 0.086
N03.1 Focal and segmental glomerular lesions
0.000 0.913 0.086
N02.3 Diffuse mesangial proliferative glomerulonephritis
0.000 0.914 0.086
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.084 0.916 0.000
N03.8 Other
0.001 0.918 0.082
L43.8 Other lichen planus
0.082 0.918 0.000
C56 Malignant neoplasm of ovary
0.000 0.919 0.081
N02.1 Focal and segmental glomerular lesions
0.000 0.919 0.081
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.079 0.921 0.000
E27.8 Other specified disorders of adrenal gland
0.000 0.922 0.077
T47.1 Other antacids and anti-gastric-secretion drugs
0.077 0.923 0.000
E04.8 Other specified non-toxic goitre
0.000 0.923 0.076
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system
0.074 0.925 0.000
E27.5 Adrenomedullary hyperfunction
0.001 0.925 0.074
E27.0 Other adrenocortical overactivity
0.001 0.925 0.074
N02.8 Other
0.000 0.925 0.075
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.926 0.074
T45.0 Antiallergic and antiemetic drugs
0.073 0.927 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.073 0.927 0.000
H36 Retinal disorders in diseases classified elsewhere
0.000 0.928 0.072
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.072 0.928 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.071 0.929 0.000
M07 Psoriatic and enteropathic arthropathies
0.069 0.930 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.069 0.931 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.069 0.931 0.000
T47.0 Histamine H(2)-receptor antagonists
0.069 0.931 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.069 0.931 0.000
T50.8 Diagnostic agents
0.068 0.932 0.000
T36 Poisoning by systemic antibiotics
0.067 0.933 0.000
T47.2 Stimulant laxatives
0.066 0.934 0.000
R40.0 Somnolence
0.000 0.934 0.066
K93 Disorders of other digestive organs in diseases classified elsewhere
0.000 0.935 0.065
T45.4 Iron and its compounds
0.065 0.935 0.000
E04.0 Non-toxic diffuse goitre
0.000 0.935 0.065
E27.9 Disorder of adrenal gland, unspecified
0.001 0.936 0.064
K86.1 Other chronic pancreatitis
0.000 0.936 0.064
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.064 0.936 0.000
K86 Other diseases of pancreas
0.000 0.937 0.063
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.063 0.937 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.063 0.937 0.000
T47.7 Emetics
0.063 0.937 0.000
T47.6 Antidiarrhoeal drugs
0.063 0.937 0.000
T47.5 Digestants
0.063 0.937 0.000
T47.4 Other laxatives
0.063 0.937 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.